Contemporary issues affecting P&T committees. Part 2: Beyond managed care

P and T

Volumn 29, Issue 12, 2004, Pages 780-783

  Balu, Sanjeev ^a   O'Connor, Paul ^b   Vogenberg, F Randy ^b  

^a PURDUE UNIVERSITY   (United States)

^b Aon Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG FORMULARY; DRUG SAFETY; HEALTH SERVICE; HUMAN; MANAGED CARE; ORGANIZATION AND MANAGEMENT; PHARMACEUTICAL CARE; PHARMACY; PRESCRIPTION; REVIEW; THERAPY;

EID: 11344258623     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. U.S. Department of Commerce, Bureau of Census. Projections of the Population of the United States, by Age, Sex, and Race: 1988-2080. Washington, DC: U.S. Government Printing Office; 1989.
2. Cross M. Increased pressures change P&T committee makeup. Managed Care, December 2001. Available at: www.managedcare mag.com/archives/0112/0112. formularycomm.html.
3. Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 2001;285:421-429.
4. Lurk JT, DeJong DJ, Woods TM, et al. Effects of changes in patient cost sharing and drug sample policies on prescription medication costs and utilization in a safety-net provider setting. Am J Health Syst Pharm 2004;61(3):267-272.
5. Nair KV, Coombs JH, Ascione FJ. Assessing the structure, activities, and functioning of P&T committees: A multisite case study. P&T 2000;25(10):516-528.
6. Fullerton DS, Atherly DS. Formularies, therapeutics, and outcomes: New opportunities. Medical Care 2004;42(4 Suppl):III39-III44.
7. Odedina FT, Sullivan J, Nash R, Clemmons CD. Use of pharmacoeconomic data in making hospital formulary decisions. Am J Health System Pharm 2002;59(15):1441-1444.
8. Drug Utilization Review: A Canadian Process and Methodology for Studies of Community-Based Drug Therapy. 2001. Available at: www.canadapharma.org/ Media_Centre/Special_Reports/DUR Process_Oct2001.pdf.
9. Hennessy S, Bilker WB, Zhou L, et al. Retrospective Drug Utilization Review, prescribing errors, and clinical outcomes. JAMA 2003;290(11):1494-1499.
10. Lichtig LK, Weinberg RM, Knauf RA, Vogenberg FR. Measuring clinical effectiveness using common hospital data. P&T 2004;29(5):304-313.
11. Vogenberg FR, Lichtig LK, Weinberg R, DeSantis V. Balancing physician and cost-containment demands. Healthcare Financial Manage Assoc 2004:66-70,72.
12. Darves B. P&T's new starting lineup. HealthLeaders, September 1, 2004, p 38 (36-40).